By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Affimed Therapeutics AG 

Technologiepark
Im Neuenheimer Feld 582
Heidelberg    69120   Germany
Phone: 49-6221-65307-0 Fax: 49-6221-65307-77


SEARCH JOBS


Industry
Biotechnology






Company News
Affimed (AFMD) Presents Data On EGFRwt and EGFRvIII-Targeting NK- And T-Cell Tandabs At The AACR Annual Meeting 2016 4/21/2016 8:31:50 AM
Affimed (AFMD) Presents Data On AFM13-Mediated Innate/Adaptive Immune Crosstalk At The AACR Annual Meeting 2016 4/21/2016 8:28:45 AM
Affimed (AFMD) Reports Financial Results For Fourth Quarter And Year End 2015 3/30/2016 10:11:10 AM
Affimed (AFMD) Announces Fourth Quarter And Year End 2015 Financial Results And Corporate Update Conference Call 3/23/2016 8:11:30 AM
Affimed (AFMD) To Present Data On NK- And T-Cell Engagers At The AACR Annual Meeting 2016 3/17/2016 8:08:24 AM
Affimed (AFMD) To Present At The Cowen and Company 36th Annual Health Care Conference 2/29/2016 7:57:48 AM
Affimed (AFMD) To Speak At Symposium On Emerging Approaches In Cancer Immunotherapy 2/22/2016 11:48:28 AM
Affimed (AFMD) To Present At The Leerink Partners 5th Annual Global Healthcare Conference 2/4/2016 7:52:39 AM
Affimed Therapeutics AG (AFMD) Enters Into Collaboration With Merck & Co. (MRK) To Evaluate AFM13 In Combination With KEYTRUDA (Pembrolizumab) For Patients With Hodgkin Lymphoma 1/25/2016 7:29:21 AM
Affimed Therapeutics AG (AFMD) To Host Hodgkin's Lymphoma Day With Key Opinion Leaders On January 26th In New York City 1/20/2016 8:07:41 AM
1234567
//-->